How to Buy Mirum Pharmaceuticals Stock
Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
Mirum Pharmaceuticals stock last closed at $38.39, down 1.82% from the previous day, and has increased 58.83% in one year. It has overperformed other stocks in the Biotechnology industry by 1.36 percentage points. Mirum Pharmaceuticals stock is currently +65.9% from its 52-week low of $23.14, and -29.21% from its 52-week high of $54.23.
As of Apr 21, 2025, there are 49.01M shares of MIRM outstanding. The market cap of MIRM is $1.88B. In the past 24 hours, 315,159 MIRM shares were traded.
How to Buy Mirum Pharmaceuticals Stock
Wondering how to invest in Mirum Pharmaceuticals stock? Here's how.
- Figure out where to buy Mirum Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Mirum Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Select your method of payment and add your details.
- Evaluate Mirum Pharmaceuticals stock: The Mirum Pharmaceuticals ticker symbol is MIRM. Is Mirum Pharmaceuticals stock a good investment? Should you buy shares of MIRM? How do MIRM's underlying business fundamentals look? Do top analysts think Mirum Pharmaceuticals is a good buy? Why has MIRM's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if MIRM is a good stock to buy).
- Execute your MIRM trade: Decide if you will purchase MIRM shares at the current market price or use a limit order to purchase MIRM shares at a specific price.
- Monitor your MIRM investment: Create a watchlist to keep tabs on your position in Mirum Pharmaceuticals shares.
Step 1: Figure out where to buy Mirum Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy MIRM shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you are able to invest in MIRM stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on investing apps, you need to deposit funds:
Check out the video below for more details transferring money into your new brokerage account.
Step 4: Evaluate Mirum Pharmaceuticals stock
Once you have figured out the best place to buy Mirum Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Mirum Pharmaceuticals quick stats
Mirum Pharmaceuticals Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on MIRM's stock page.
Is MIRM stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge MIRM's true value.
Using relative valuations methods:
- MIRM could be overvalued based on its P/B ratio of 8.34x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation analysis on MIRM's stock here.
MIRM Financial Overview
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the MIRM balance sheet.
- There are more short-term assets than short-term liabilities on the MIRM balance sheet.
Negative Financial Indicators:
- Total MIRM debt is higher than 5 years ago, relative to shareholder equity.
- MIRM profit margin has gone up by 0.62 percentage points in the past year, but the company is still unprofitable.
- MIRM earnings of -$72.60M is not enough to cover its interest payments.
- MIRM's operating cash flow of $10.33M allows it to safely service it's debt of $317.76M.
- MIRM has a relatively high debt to equity ratio of 1.97.
Is it a good time to buy MIRM stock, according to analysts?
Out of 4 Wall Street analysts who research MIRM, the consensus analyst rating on MIRM is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Mirum Pharmaceuticals stock forecast page.
MIRM Technical Indicators
Is MIRM Making Money?
Last year, MIRM revenue was $336.89M. During the last 3 year, MIRM's revenue has grown by 255.11% per year. This was faster than the Biotechnology industry average of 44.31%.
You can research MIRM's earnings and revenue performance here.
Latest Insiders Trades at MIRM
In the past year, insiders at MIRM have sold more shares than they have bought.
Jolanda Howe, SVP GLOBAL CONTROLLER of MIRM, was the latest MIRM insider to sell. They sold $107,341.92 worth of MIRM shares on Mar 18, 2025.
Get more info about who owns MIRM shares here.
Can I get consistent income from MIRM stock?
No, Mirum Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about MIRM
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your MIRM trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and eToro will execute your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your MIRM investment
Now that you own some shares in MIRM, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to see the latest developments about your MIRM stock.
MIRM Feed
How to Buy Stock in Mirum Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Mirum Pharmaceuticals:
- Figure out where to buy Mirum Pharmaceuticals stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Mirum Pharmaceuticals stock
- Execute your MIRM trade
- Monitor your MIRM investment
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Mirum Pharmaceuticals, add MIRM to your watchlist by clicking the button below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.